Animal Antibiotics and Antimicrobials Market to Grow with a CAGR of 3.55% through 2029

Rising demand for livestock-products is expected to drive the Global animal antibiotics and antimicrobials market in the forecast period, 2025-2029

According to TechSci Research report, “Animal Antibiotics and Antimicrobials Market–Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F,” the global Animal Antibiotics and Antimicrobials market stood at USD 4.90 billion in 2023 and is anticipated to grow at a CAGR of 3.55% in the forecast period, 2025-2029. This trend can be attributed to several factors, including the increased demand for livestock-based products and the growing prevalence of infectious diseases in animals. Furthermore, the rising ownership of companion animals is driving the expansion of the global antibiotic and antimicrobials market.

Antimicrobials and antibiotics are essential in the prevention and treatment of infectious diseases in animals. With greater awareness of the impact of diseases on animal health and welfare, there is a heightened focus on the use of these medications to effectively control infections. Timely and effective treatment can alleviate animal suffering, prevent the spread of diseases within herds or flocks, and reduce economic losses associated with outbreaks.

The expanding investment in animal healthcare and the increasing adoption of pet insurance policies are key drivers fueling the growth of the antimicrobials and antibiotics market. This trend is anticipated to continue driving market expansion in the foreseeable future. Pet owners are progressively prioritizing veterinary care to safeguard the health of their companion animals, encompassing routine examinations, vaccinations, and treatment for various health conditions. Consequently, there is a rising demand for antibiotic and antimicrobial therapies in veterinary settings to combat bacterial infections and manage infectious diseases in companion animals. Furthermore, common veterinary procedures such as spaying, neutering, and other surgeries in companion animals necessitate the use of antimicrobials and antibiotics to prevent and treat postoperative infections.

Antimicrobial and antibiotic medications are instrumental in eradicating or controlling bacterial infections, thereby reducing disease transmission within animal populations and mitigating the risk of zoonotic transmission. However, the prudent use of antibiotics and antimicrobials in animals is crucial. Accurate diagnosis, prescription, and adherence to dosage regimens are essential to mitigate the emergence and spread of antibiotic resistance, safeguard public health, alleviate animal suffering, and promote animal welfare.

Withthe escalation of global trade and animal movement, the risk of disease introduction from one region to another has heightened. Antibiotics and antimicrobials contribute to biosecurity measures by preventing the entry and spread of diseases. Quarantine protocols often entail antimicrobial treatments to ensure animals are free from contagious diseases before integration into new populations.

Challenges such as the rise of antimicrobial resistance, limited antibiotic discovery, and increasing awareness of good husbandry practices among companion and production animal owners pose obstacles to the growth of the antimicrobials and antibiotics market. These factors underscore the significance of responsible antibiotic use and emphasize the need for ongoing efforts to address antimicrobial resistance and promote sustainable animal healthcare practices.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " Global Animal Antibiotics & Antimicrobials Market”

The Global Animal Antibiotics & Antimicrobials Market is segmented into product , mode of delivery, animal type, regional distribution, and company.

Based on mode of delivery, the market is segmented into premixes, oral solution, injections. The oral solution segment is expected to hold the largest share in the antimicrobial and antibiotic market in the forecast period. Oral solutions are liquid formulations of antibiotics and antimicrobials that are administered orally to animals. These solutions are commonly used in veterinary medicine for the treatment of bacterial infections, respiratory diseases, and gastrointestinal disorders in livestock, poultry, and companion animals. Oral solutions offer several advantages, including ease of administration, rapid absorption, and flexibility in dosing. The dominance of oral solutions in the Global Animal Antibiotics and Antimicrobials Market is driven by their versatility and convenience in treating a wide range of bacterial infections in animals. Livestock producers and veterinarians often prefer oral solutions for their effectiveness in targeting specific pathogens, as well as their ability to deliver antibiotics directly to the site of infection.

Also, oral solutions are suitable for use in both individual and group treatment settings, making them well-suited for addressing disease outbreaks in animal populations. Their ease of use and relatively low cost compared to other modes of delivery contribute to their popularity among livestock producers and veterinary practitioners worldwide.. This is leading to increased market demand and growth.

Based on region, North America is poised to witness fastest market growth in the global animal antibiotics & antimicrobials market. This is due to the reason that North America possesses a robust research and development infrastructure, marked by substantial investments in veterinary medicine, pharmaceuticals, and biotechnology. Leading pharmaceutical firms, research institutions, and academic centers in the region are at the forefront of innovation in animal health products, including antibiotics and antimicrobials. Technological advancements such as gene editing, molecular diagnostics, and targeted drug delivery systems are revolutionizing the development and delivery of veterinary pharmaceuticals, enhancing their efficacy, safety, and sustainability. Moreover, North America upholds stringent regulatory standards and oversight mechanisms governing the use of antibiotics and antimicrobials in animal agriculture. Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the Canadian Food Inspection Agency (CFIA) in Canada enforce rigorous regulations on antibiotic use, antimicrobial resistance monitoring, and veterinary drug approval processes. These regulatory frameworks ensure responsible antibiotic use in animal health and welfare, thereby mitigating the risk of antimicrobial resistance and safeguarding public health.

There is a growing awareness and emphasis on animal welfare and health in North America, driven by consumer demand, industry initiatives, and regulatory mandates. Livestock producers, veterinarians, and industry stakeholders are adopting holistic approaches to animal management, focusing on preventive healthcare, disease management strategies, and responsible antibiotic use. This shift toward sustainable and ethical animal production practices presents opportunities for innovative antibiotic alternatives, precision medicine solutions, and integrated disease management approaches that prioritize animal welfare and health outcomes. Furthermore, North America has witnessed significant expansion in intensive livestock farming practices, particularly in sectors such as poultry, swine, and dairy production. Large-scale commercial operations, confined animal feeding operations (CAFOs), and integrated livestock systems are increasingly prevalent to meet the rising demand for animal protein products. Intensive farming systems often rely on antibiotics and antimicrobials for disease prevention, control, and growth promotion, thereby driving demand in the animal health market.

Major companies operating in the Global Animal Antibiotics & Antimicrobials Market are:

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Merck & co. Inc.
• Elanco Animal Health Incorporated
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Virbac S.A.
• HIPRA S.A.
• Ceva Sante Animale SA
• Kyoritsuseiyaku Corporation

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The rising health concerns among companion and productive animals are major factors that contribute significantly to the demand for the global antimicrobials and antibiotic market. Additionally, the growing trend of owning companion animals as pets, coupled with the increasing opportunities arising from the expanding livestock industry in countries like India, China, Brazil, etc., is expected to drive the expansion of the global antimicrobials and antibiotic market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“Animal Antibiotics and Antimicrobials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), By Mode of Delivery (Premixes, Oral Solutions, Injection), By Animal Type (Food Producing, Companion), By Region, and Competition, 2019-2029F” has evaluated the future growth potential of Global Animal Antibiotics & Antimicrobials Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Animal Antibiotic & Antimicrobials Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com